NASDAQ · Financial Statements
KALA BIO, Inc. (KALA) Financial Statements
$0.29
NASDAQ: KALA
Market Cap $5.68M
Overview Financials Dividend
KALA BIO, Inc. most recently reported annual revenue of $0, a net loss of $27.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $11.0M $4.0M $0 $0 $0 Operating Profit $-109.0M $-81.0M $-39.0M $-40.0M $-39.0M Net Profit $-143.0M $-45.0M $-42.0M $-39.0M $-27.0M EPS $-108.32 $-1474.00 $-867.50 $-507.50 $-165.50 Op Margin -973.6% -2090.3% — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $139.0M $87.0M $56.0M $55.0M $9.0M Total Liabilities $123.0M $68.0M $48.0M $43.0M $2.0M Cash $92.0M $70.0M $51.0M $51.0M $8.0M Borrowings $80.0M $43.0M $36.0M $32.0M $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-108.0M $-79.0M $-28.0M $-29.0M $-32.0M Investing Cash Flow $70.0M $62.0M $-1.0M $0 $0 Financing Cash Flow $2.0M $0 $-2.0M $0 $0 Net Cash Flow $5.0M $-24.0M $-20.0M $0 $-44.0M Free Cash Flow $-109.0M $-79.0M $-29.0M $-30.0M $-32.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.82 FCF Yield -266.77% Quick Ratio 6.88 Interest Coverage -19.01 Return 1Y -99.62% Return 3Y -99.86% Return 5Y -99.99%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .